Form preview

Get the free Phase III- Clinical trial with once a month combined injectable contraceptive Lunell...

Get Form
This document provides a summary report of a Phase III clinical trial evaluating the contraceptive efficacy, side effects, and overall acceptability of the once-a-month combined injectable contraceptive
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign phase iii- clinical trial

Edit
Edit your phase iii- clinical trial form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your phase iii- clinical trial form via URL. You can also download, print, or export forms to your preferred cloud storage service.

Editing phase iii- clinical trial online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
Here are the steps you need to follow to get started with our professional PDF editor:
1
Create an account. Begin by choosing Start Free Trial and, if you are a new user, establish a profile.
2
Simply add a document. Select Add New from your Dashboard and import a file into the system by uploading it from your device or importing it via the cloud, online, or internal mail. Then click Begin editing.
3
Edit phase iii- clinical trial. Rearrange and rotate pages, add new and changed texts, add new objects, and use other useful tools. When you're done, click Done. You can use the Documents tab to merge, split, lock, or unlock your files.
4
Save your file. Select it from your list of records. Then, move your cursor to the right toolbar and choose one of the exporting options. You can save it in multiple formats, download it as a PDF, send it by email, or store it in the cloud, among other things.
pdfFiller makes working with documents easier than you could ever imagine. Try it for yourself by creating an account!

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out phase iii- clinical trial

Illustration

How to fill out Phase III- Clinical trial with once a month combined injectable contraceptive Lunelle/Cyclofem

01
Review the trial protocol for Phase III to understand inclusion and exclusion criteria.
02
Obtain informed consent from participants, explaining the purpose and procedures of the trial.
03
Recruit eligible participants who meet the criteria for the trial.
04
Schedule baseline assessments for each participant, including health history and physical examinations.
05
Administer the combined injectable contraceptive Lunelle/Cyclofem to participants on the designated schedule (once a month).
06
Monitor participants for any side effects or adverse reactions after administration.
07
Conduct regular follow-ups to assess the effectiveness of the contraceptive and collect data on any changes in health.
08
Collect and analyze data throughout the trial to evaluate the safety and efficacy of Lunelle/Cyclofem.

Who needs Phase III- Clinical trial with once a month combined injectable contraceptive Lunelle/Cyclofem?

01
Women of reproductive age who are seeking a reliable and convenient contraceptive method.
02
Women who may not be able to use oral contraceptives due to health conditions or personal preferences.
03
Healthcare providers looking to offer new contraceptive options that may enhance patient compliance.
04
Researchers studying the efficacy and safety of monthly injectable contraceptives.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.0
Satisfied
42 Votes

People Also Ask about

The main disadvantage of both methods is menstrual irregularity. Weight gain and bone pain in DMPA users, while headache and tenderness in Cyclofem users were also observed as the most important side effects.
The biggest difference is that Cyclofem® and Mesigyna® contains estrogen and progestin and ® only has progestin. You have to get a shot once every month with Cyclofem® and Mesigyna®, whereas only once every three months with ®.
Cyclofem proved its use-effectiveness (pregnancy rate of 0.03%) and its safety under routine service conditions of family planning facilities in Mexico. The overall life table continuation rate at 1 year was 26.1%.
LUNELLE Monthly Contraceptive Injection is indicated for the prevention of pregnancy. The efficacy of LUNELLE Monthly Contraceptive Injection is dependent on adherence to the recommended dosage schedule (e.g., intramuscular injections every 28 to 30 days, not to exceed 33 days).
Cyclofem is a combined injectable contraceptive, containing medroxyprogesterone acetate (MPA) and cypionate.
is a well-known brand name for medroxyprogesterone acetate. It's a birth control shot that has the hormone progestin. A birth control shot is also called a contraceptive injection. People who take get a shot every three months.
Cyclofem proved its use-effectiveness (pregnancy rate of 0.03%) and its safety under routine service conditions of family planning facilities in Mexico. The overall life table continuation rate at 1 year was 26.1%.

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

Phase III clinical trials for Lunelle/Cyclofem are studies that assess the effectiveness, safety, and optimal dosage of the once-a-month combined injectable contraceptive in a larger population, following initial testing in earlier phases.
The entity sponsoring the clinical trial, typically a pharmaceutical company or research institution, is required to file the necessary documentation for Phase III clinical trials of Lunelle/Cyclofem with regulatory authorities.
To fill out Phase III clinical trial documentation for Lunelle/Cyclofem, sponsors need to provide detailed information about the trial design, participant demographics, treatment protocols, safety monitoring plans, and statistical analysis plans.
The purpose of Phase III trials for Lunelle/Cyclofem is to validate the contraceptive's efficacy and safety in a larger population, assess its real-world applicability, and support the submission for regulatory approval.
Reports on Phase III clinical trials of Lunelle/Cyclofem must include details such as trial outcomes, side effects, adherence rates, demographic data of participants, statistical findings, and any adverse events encountered during the study.
Fill out your phase iii- clinical trial online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.